These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 24835321)

  • 1. Prognostic value of access site and nonaccess site bleeding after percutaneous coronary intervention: a cohort study in ST-segment elevation myocardial infarction and comprehensive meta-analysis.
    Kikkert WJ; Delewi R; Ouweneel DM; van Nes SH; Vis MM; Baan J; Koch KT; Dangas GD; Mehran R; de Winter RJ; Peters RJ; Piek JJ; Tijssen JG; Henriques JP
    JACC Cardiovasc Interv; 2014 Jun; 7(6):622-30. PubMed ID: 24835321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of bleeding academic research consortium (BARC)-defined bleeding complications in ST-segment elevation myocardial infarction: a comparison with the TIMI (Thrombolysis In Myocardial Infarction), GUSTO (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries), and ISTH (International Society on Thrombosis and Haemostasis) bleeding classifications.
    Kikkert WJ; van Geloven N; van der Laan MH; Vis MM; Baan J; Koch KT; Peters RJ; de Winter RJ; Piek JJ; Tijssen JG; Henriques JP
    J Am Coll Cardiol; 2014 May; 63(18):1866-75. PubMed ID: 24657697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent myocardial infarction after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Kikkert WJ; Hoebers LP; Damman P; Lieve KV; Claessen BE; Vis MM; Baan J; Koch KT; de Winter RJ; Piek JJ; Tijssen JG; Henriques JP
    Am J Cardiol; 2014 Jan; 113(2):229-35. PubMed ID: 24188893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRUSADE bleeding risk score validation for ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Ariza-Solé A; Sánchez-Elvira G; Sánchez-Salado JC; Lorente-Tordera V; Salazar-Mendiguchía J; Sánchez-Prieto R; Romaguera-Torres R; Ferreiro-Gutiérrez JL; Gómez-Hospital JA; Cequier-Fillat A
    Thromb Res; 2013; 132(6):652-8. PubMed ID: 24112751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radial versus femoral access for primary percutaneous interventions in ST-segment elevation myocardial infarction patients: a meta-analysis of randomized controlled trials.
    Karrowni W; Vyas A; Giacomino B; Schweizer M; Blevins A; Girotra S; Horwitz PA
    JACC Cardiovasc Interv; 2013 Aug; 6(8):814-23. PubMed ID: 23968700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-hospital major bleeding and its clinical relevance in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Boden H; Velders MA; van der Hoeven BL; Cannegieter SC; Schalij MJ
    Am J Cardiol; 2013 Nov; 112(10):1533-9. PubMed ID: 23953696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between intraprocedural thrombotic events and adverse outcomes after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (a Harmonizing Outcomes With RevasculariZatiON and Stents in Acute Myocardial Infarction [HORIZONS-AMI] Substudy).
    Kirtane AJ; Sandhu P; Mehran R; McEntegart M; Cristea E; Brener SJ; Xu K; Fahy M; Généreux P; Wessler JD; Stone GW
    Am J Cardiol; 2014 Jan; 113(1):36-43. PubMed ID: 24169019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of outcomes after percutaneous coronary intervention among different coronary subsets (stable and unstable angina pectoris and ST-segment and non-ST-segment myocardial infarction).
    Loh JP; Pendyala LK; Kitabata H; Torguson R; Omar A; Minha S; Chen F; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2014 Jun; 113(11):1794-801. PubMed ID: 24837256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ST-segment elevation myocardial infarction treated by radial or femoral approach in a multicenter randomized clinical trial: the STEMI-RADIAL trial.
    Bernat I; Horak D; Stasek J; Mates M; Pesek J; Ostadal P; Hrabos V; Dusek J; Koza J; Sembera Z; Brtko M; Aschermann O; Smid M; Polansky P; Al Mawiri A; Vojacek J; Bis J; Costerousse O; Bertrand OF; Rokyta R
    J Am Coll Cardiol; 2014 Mar; 63(10):964-72. PubMed ID: 24211309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radial versus femoral access is associated with reduced complications and mortality in patients with non-ST-segment-elevation myocardial infarction: an observational cohort study of 10,095 patients.
    Iqbal MB; Arujuna A; Ilsley C; Archbold A; Crake T; Firoozi S; Kalra S; Knight C; Lim P; Malik IS; Mathur A; Meier P; Rakhit RD; Redwood S; Whitbread M; Bromage D; Rathod K; Wragg A; MacCarthy P; Dalby M;
    Circ Cardiovasc Interv; 2014 Aug; 7(4):456-64. PubMed ID: 24963013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing and long-term prognosis of recurrent MI after primary angioplasty : Stent thrombosis vs. non-stent-related reinfarction.
    Viveiros Monteiro A; Ramos R; Fiarresga A; de Sousa L; Cacela D; Patrício L; Bernardes L; Soares C; Cruz Ferreira R
    Herz; 2017 Apr; 42(2):186-193. PubMed ID: 27363417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of radial versus femoral artery access in patients with acute coronary syndromes with or without ST-segment elevation.
    Mehta SR; Jolly SS; Cairns J; Niemela K; Rao SV; Cheema AN; Steg PG; Cantor WJ; Džavík V; Budaj A; Rokoss M; Valentin V; Gao P; Yusuf S;
    J Am Coll Cardiol; 2012 Dec; 60(24):2490-9. PubMed ID: 23103036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of mortality after severe bleeding and recurrent myocardial infarction in patients with ST-segment-elevation myocardial infarction.
    Kikkert WJ; Zwinderman AH; Vis MM; Baan J; Koch KT; Peters RJ; de Winter RJ; Piek JJ; Tijssen JG; Henriques JP
    Circ Cardiovasc Interv; 2013 Aug; 6(4):391-8. PubMed ID: 23941861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors and prognostic consequence of gastrointestinal bleeding in patients with ST-segment elevation myocardial infarction.
    Kikkert WJ; Hassell MECJ; Delewi R; van der Laan MH; Baan J; Vis MM; Koch KT; de Winter RJ; Piek JJ; Tijssen JGP; Henriques JPS
    Int J Cardiol; 2015 Apr; 184():128-134. PubMed ID: 25703420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ischemic outcomes after coronary intervention of calcified vessels in acute coronary syndromes. Pooled analysis from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) and ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) TRIALS.
    Généreux P; Madhavan MV; Mintz GS; Maehara A; Palmerini T; Lasalle L; Xu K; McAndrew T; Kirtane A; Lansky AJ; Brener SJ; Mehran R; Stone GW
    J Am Coll Cardiol; 2014 May; 63(18):1845-54. PubMed ID: 24561145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of neutrophil/lymphocyte ratio in patients with ST-elevated myocardial infarction undergoing primary coronary intervention: a prospective, multicenter study.
    Kaya MG; Akpek M; Lam YY; Yarlioglues M; Celik T; Gunebakmaz O; Duran M; Ulucan S; Keser A; Oguzhan A; Gibson MC
    Int J Cardiol; 2013 Sep; 168(2):1154-9. PubMed ID: 23219132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of cigarette smoking on extent of coronary artery disease and prognosis of patients with non-ST-segment elevation acute coronary syndromes: an analysis from the ACUITY Trial (Acute Catheterization and Urgent Intervention Triage Strategy).
    Robertson JO; Ebrahimi R; Lansky AJ; Mehran R; Stone GW; Lincoff AM
    JACC Cardiovasc Interv; 2014 Apr; 7(4):372-9. PubMed ID: 24630881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial.
    Vink MA; Dirksen MT; Suttorp MJ; Tijssen JG; van Etten J; Patterson MS; Slagboom T; Kiemeneij F; Laarman GJ
    JACC Cardiovasc Interv; 2011 Jan; 4(1):24-9. PubMed ID: 21251625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radial vs femoral access after percutaneous coronary intervention for ST-segment elevation myocardial infarction. Thirty-day and one-year mortality results.
    Ruano-Ravina A; Aldama-López G; Cid-Álvarez B; Piñón-Esteban P; López-Otero D; Calviño-Santos R; Ocaranza-Sánchez R; Vázquez-González N; Trillo-Nouche R; López-Pardo E
    Rev Esp Cardiol (Engl Ed); 2013 Nov; 66(11):871-8. PubMed ID: 24773994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of kidney function in patients with ST-elevation and non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention.
    Seyfarth M; Kastrati A; Mann JF; Ndrepepa G; Byrne RA; Schulz S; Mehilli J; Schömig A
    Am J Kidney Dis; 2009 Nov; 54(5):830-9. PubMed ID: 19592145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.